Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

Despite the price drops, the drugs remain costly. Novo Nordisk cut the price of Wegovy by 23 percent for cash payments from ...

Laura Davisson is an obesity medicine doctor and professor at West Virginia University, but a growing part of her job is not ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The CMS last month declined to include anti-obesity medications in its Medicare coverage for Part D, a move that Lilly says could interfere with patients getting the appropriate medical care.

UnitedHealthcare dealt another blow to its Medicare agents when it announced last week it will not pay commissions on Medicare prescription drug plans sold after June 1. The announcement was the ...

A worker tags young cannabis plants at a marijuana farm operated by Greenlight on Oct. 31, 2022, in Grandview, Mo. NINA MOINI: Sleep apnea is a condition that affects millions of people, often ...

Participants who received tirzepatide, the active ingredient in Zepbound, also had greater reductions ... these treatments with changes in diet, sleep, movement, and stress — things we work ...

Standard treatment for breathing problems caused by obstructive sleep apnea is a medical device. But many people find it uncomfortable to wear the mask that comes with a continuous positive airway ...

When you first sign up for Medicare, you may come across many terms and abbreviations. Learning the definitions of these can help you understand Medicare better. Medicare information can be confusing.